Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass)
Viktor Grünwald, Philipp Ivanyi, Stefanie Zschäbitz, Manfred P. Wirth et autres
11 citationsEuropean Urology